Sectors

Asian health-care sector stirs private equity interest

Date: 12 Mar 2010

A brace of private equity deals in Asia’s health-care sector last week showcased the market’s potential. With the M&A pipeline looking crowded, deal-making in this sector is likely to heat up in 2010, writes mergermarket.

Keywords (click to search): [private equity] [Mergermarket] [Parkway Holdings] [Fortis Healthcare] [Khazanah] [TPG Capital] [CHA Bio & Diostech] [New Silk Route] [Nectar Lifesciences]

Private equity interest in Asia’s health-care market could be set to soar after a brace of transactions last week, both of which showcase the sector’s potential growth.

The larger of the two deals saw the management of Singaporean health-care services provider Parkway Holdings, backed by India-based Fortis Healthcare, buy a 23.9% stake in the business, for US$685.3 million.

The deal represents a successful divestment for TPG Capital, which previously purchased...

To continue reading the rest of the article, you will need to be an Asiamoney subscriber.

Asiamoney subscribers will receive full access to the following:

  • All the latest news, analysis and opinion at Asiamoney.com, Asiamoney WM (Wealth Management), and ACN (Asiamoney China) .
  • Breaking news alerts sent directly to your PC/mobile device.
  • Asiamoney’s Polls and Awards section.
  • Asiamoney’s extensive online archive
  • Asiamoney Week: our email service featuring the most widely read news and opinion pieces on Asia’s financial markets from our website over the previous seven days

If you would like to start your subscription, please contact our subscriptions team at (+852) 2842 6998.

If you are experiencing any problems with your access, please contact Customer Service by phone at (+852) 2842 6910 (Hong Kong), (+44) (0) 20 7779 8999 (UK), (+1) 212 224 3570 (US) or contact us by email at subscriptions@asiamoney.com.

Kind regards,

Asiamoney
http://www.asiamoney.com


Already have an account?

Subscriber Login


Forgotten your password?

Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Free trial

Taking a free trial will give you access to the current issue for two weeks (excluding selected articles, poll results and achives). Start your free trial today.

Related articles